You must log in to view this page.

Zentalis Pharmaceuticals Inc. – Filings and Transcripts

NASDAQ: ZNTL
Share price (3/27/26): $2.10
Market cap (3/27/26): $149 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Registration of securities for employees

Shelf registration

Registration of securities for employees

Automatic shelf registration

Prospectus supplement for primary offering

Ownership Filter

Squadron Capital Management LLC

Vultaggio Vincent

Eastland Julia Marie

Vultaggio Vincent

News Filter

Reports Full Year 2025 Financial Results and Operational Updates

Investor Presentation

Change in Directors, Officers or Compensation, Other Events

Reports Third Quarter 2025 Financial Results and Operational Progress

Appoints James B. Bucher, JD, as Chief Legal Officer and Corporate Secretary

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Letter from the SEC